Medicaid Expansion May Result in Earlier Colon Cancer Diagnosis, Study SaysDecember 13th 2020
The authors wrote that in states that expanded Medicaid health insurance coverage in 2014, there was an increase of early-stage colon cancer diagnoses compared with states that did not implement expansion.
AI Helps Determine Which Patients Benefit Most From Colorectal Cancer TreatmentDecember 9th 2020
Researchers found the application of FOLFOXai, an artificial intelligence (AI)–based predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer (mCRC), may lead to improved treatment outcomes for some patients with mCRC and other cancers.
Impact of Travel Distance on Quality Outcomes in Colorectal Cancer
This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.
Biomarker Use in Colorectal CancerDecember 18th 2019
Despite a 20% drop in mortality since 2009, colorectal cancer accounted for 9.8% (881,000) of deaths worldwide in 2018 and represents 10.2% of all cancer cases worldwide. It is No. 3 on the list of most prevalent cancers worldwide—1.8 million new cases in 2018—behind only lung cancer and breast cancer.
NGS Identifies Survival, Treatment Outcomes for Patients With CRC Genetic MutationsApril 7th 2019
Genetic alternations in colorectal cancer (CRC) are linked to different survival and treatment outcomes, according to a study that used next-generation sequencing (NGS) of tumor DNA. The study was published in Journal of Clinical Oncology.